Back to Results
First PageMeta Content
GlaxoSmithKline / Rosiglitazone / Medicine / Pharmaceutical sciences / Pioglitazone / Anti-diabetic medication / Food and Drug Administration / Victor Montori / Pyridines / Thiazolidinediones / Chemistry


World Report The long Avandia endgame 1 year after drug regulators finished re-reviewing Avandia’s safety profile, the diabetes community is still left unsettled by the case. Asher Mullard reviews the lessons learne
Add to Reading List

Open Document

File Size: 34,74 KB

Share Result on Facebook

Company

GlaxoSmithKline / Glaxosmithkline plc / /

Country

United States / United Kingdom / /

Currency

GBP / /

Event

FDA Phase / /

Facility

University of Oxford Diabetes Trials Unit / Mayo Clinic / Duke Clinical Research Institute / /

MedicalCondition

bladder cancer / diabetes / /

Organization

U.S. Congress / Duke Clinical Research Institute / Yale School of Medicine / European Union / European Medicine Agency / Oxford Diabetes Trials Unit / US Food and Drud Administration / /

Person

Rury Holman / Victor Montori / Thomas Marciniak / Harlan Krumholz / Asher Mullard / /

Position

cardiologist / director of the University / director / /

Product

pioglitazone / Actos / Avandia / rosiglitazone / USA / /

URL

www.thelancet.com / /

SocialTag